SRE
61
14
RL
76
3
ZBH
48
-2
FFIV
64
2
ABBV
64
4
CI
49
3
HSIC
53
2
PBI
58
8
VLO
45
6
XEL
60
-2
TSN
38
-2
AFL
66
2
GOOG
75
2
MNST
59
2
NUE
40
-3
ECL
84
2
L
63
3
OXY
46
2
BRK.B
47
2
HST
39
-5
SRE
61
14
RL
76
3
ZBH
48
-2
FFIV
64
2
ABBV
64
4
CI
49
3
HSIC
53
2
PBI
58
8
VLO
45
6
XEL
60
-2
TSN
38
-2
AFL
66
2
GOOG
75
2
MNST
59
2
NUE
40
-3
ECL
84
2
L
63
3
OXY
46
2
BRK.B
47
2
HST
39
-5
Financhill
Back

Alpine Immune Sciences 10K Form

Buy
96

ALPN
Alpine Immune Sciences

Last Price:
65.00
Seasonality Move:
27.16%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ALPN News And Ratings

See the #1 stock for the next 7 days that we like better than ALPN

ALPN Financial Statistics

Sales & Book Value

Annual Sales: $58.88M
Cash Flow: $-27.71M
Price / Cash Flow: 0
Annual Sales: $5.08
Price / Book: 13.4

Profitability

EPS (TTM): -0.64000
Net Income (TTM): $-36.84M
Gross Margin: $0
Return on Equity: -15.86%
Return on Assets: -12.21%

Alpine Immune Sciences Earnings Forecast

Key Alpine Immune Sciences Financial Ratios

  • The Selling, General & Administrative Expenses for ALPN have been equal to 37.74% of Gross Profit Margin.
  • The Research & Development expenses have been 137.41% of Revenue.
  • The Interest Expense is -0.30% of Operating Income.
  • The Net Earning history of ALPN is -54.66% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 7 years.

Alpine Immune Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ALPN
CUSIP: 02083G
Website: alpineimmunesciences.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 9.56
Quick Ratio: 9.5

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ALPN Technical Analysis vs Fundamental Analysis

Buy
96
Alpine Immune Sciences (ALPN) is a Buy

Is Alpine Immune Sciences a Buy or a Sell?